A systematic retrospective analysis in a tertiary clinical center revealed an increased incidence of serious infections during the first course of anti TNF-therapy (10.5 +/- 86.9 per 100 patient-years, in comparison with 3.4 +/- 38.7 before TNF-therapy), with a number needed to harm of 14 [16]. Here, TNF is linked to infection.